London, United Kingdom
ADVANCED COURSES & SEMINARS
Chairs: R. Valdagni, IT - H. Van Poppel, BE
MOST OF THE SPEAKER'S SLIDE PRESENTATIONS ARE AVAILABLE ON E-ESO WEBSITE.
The European School of Oncology is pleased to announce the 4th edition of "ESO Prostate Cancer Observatory: innovation and care in the next 12 months", which will be held during the EAU17 Congress on March 24 in London, chaired by Prof. H. van Poppel and Prof. R. Valdagni.
AIMS AND OBJECTIVES
ESO Observatories are high level sessions organized during major international congresses with the aim of providing the audience with updated and unbiased information on a given topic. An ESO Observatory lasts about 1 hour and half and concentrates on a forecast given by a panel of experts of what is expected to happen in their own field in the coming 12 months. The Panel includes distinguished clinicians and scientists and a patient advocate.
The forecast by each Panelist is given in the form of take-home concise message with a 7 minute presentation followed by 3 minutes of discussion. The forecast will be discussed by the panel.
|The Observatory will be held during the|
Under the auspices of
European School of Oncology
Via Turati 29
20121 Milan, Italy
Email: email@example.com - Tel +39 02 85464523
The Observatory will be held during the EAU Annual Congress.
10:00-11:45 - Room Vienna (Boulevard, Level 1)
One Western Gateway
Royal Victoria Dock
London, E16 1XL
The main entrance for EAU17 is the East entrance.
Attendance is granted to all participants registered to the EAU17 Congress.
If you wish to know more about Prostate Cancer Observatories, you can go to here to have a look on the past editions.
M. Bolla, Grenoble, FR
L. Denis, Antwerp, BE
M. De Santis, Coventry, UK
D. Tilki, Hamburg, DE
U. Haberkorn, Heidelberg, DE
S. Joniau, Leuven, BE
C. Moore, London, UK
R. Valdagni, Milan, IT
T. van der Kwast, Toronto, CA
H. Van Poppel, Leuven, BE
N. Zaffaroni, Milan, IT
|10:05||The researcher’s perspective|
N. Zaffaroni, IT
|10:15||The urologist’s perspective on surgery |
D. Tilki, DE
|10:25|| The urologist’s perspective on active surveillance|
S. Joniau, BE
|10:35||The imaging specialist’s perspective on MRI|
C. Moore, UK
|10:45|| The pathologist’s perspective|
T. van der Kwast, CA
The radiation oncologist’s perspective
|11:05||The medical oncologist’s perspective|
M. De Santis, UK
|11:15 ||The imaging specialits’s perspective on PSMA|
U. Haberkorn, DE
|11:25||The patient’s perspective|
L. Denis, BE
|11:35||Discussion and take home messages|